NDUFA3

NDUFA3 is a supernumerary (accessory) subunit of mitochondrial respiratory complex I that is required for assembly and stability of the holoenzyme (PMID:24717771, PMID:41038977). It is positioned in the peripheral (extramembrane) arm, where its knockdown impairs formation of the electron-transferring Q module, a defect resolvable by analysis of complex I assembly intermediates (PMID:24717771); cryo-EM of Drosophila complex I confirms the positional conservation of an NDUFA3 structural homologue in the peripheral arm (PMID:36622099). Loss of NDUFA3 reduces the levels of both complex I and complex IV, impairs endogenous respiration, and lowers ATP generation, and re-expression of wild-type — but not the p.Arg58His mutant — protein restores complex I and IV levels, establishing a direct functional requirement (PMID:41038977). In pathological settings NDUFA3 acts upstream of ROS-mediated cell death: its loss promotes ROS accumulation, loss of mitochondrial membrane potential, and apoptosis reversible by ROS scavenging, and its transcription is controlled by HDAC/H3K27ac chromatin modification (PMID:39256449) and by the Nrf1 transcription factor, whose suppression links NDUFA3 deficiency to mitochondrial fission, blocked mitophagy, and ZBP1-mediated PANoptosis (PMID:38942784). Biallelic loss-of-function and aberrant-splicing mutations in NDUFA3 cause Leigh syndrome, confirmed by functional rescue in patient-derived fibroblasts (PMID:41038977, PMID:41404351, PMID:39661167).

1. 2014 High

   Established that NDUFA3 is functionally required for complex I biogenesis rather than dispensable, by showing its loss stalls assembly at a defined intermediate.

   Evidence miRNA knockdown in human cell lines with blue-native PAGE analysis of assembly intermediates

   PMID:24717771

   Open questions at the time

   • Did not resolve the atomic position of NDUFA3 within the Q module
   • Mechanism of how NDUFA3 promotes Q module assembly not defined
   • No in vivo or disease relevance established at this stage
2. 2023 High

   Confirmed the structural placement and evolutionary conservation of NDUFA3 in the complex I peripheral arm.

   Evidence Cryo-EM structure determination of isolated Drosophila complex I

   PMID:36622099

   Open questions at the time

   • Structural data from Drosophila homologue, not mammalian NDUFA3 directly
   • Does not address regulation or pathological roles
3. 2024 Medium

   Demonstrated NDUFA3 dosage controls mitochondrial fitness and ROS-driven apoptosis, and identified chromatin-level transcriptional regulation.

   Evidence Lentiviral overexpression and siRNA knockdown in human nucleus pulposus cells with ROS, membrane potential, OCR, complex I activity readouts; HDAC inhibitor and H3K27ac ChIP assays

   PMID:39256449

   Open questions at the time

   • Single cell type (nucleus pulposus) limits generality
   • Direct transcription factor binding to NDUFA3 not mapped
   • Causal chain from complex I loss to apoptosis inferred via NAC rescue, not dissected
4. 2024 Medium

   Placed NDUFA3 within an upstream signaling cascade where its suppression triggers a defined cell-death program in sepsis endothelium.

   Evidence S100A8/A9 treatment of endothelial cells with pathway epistasis readouts (Nrf1, complex I activity, Sirt1, mitochondrial morphology, ZBP1-mediated PANoptosis); scRNA-seq and bulk RNA-seq

   PMID:38942784

   Open questions at the time

   • Nrf1 regulation of Ndufa3 shown by expression correlation, direct promoter binding not established
   • Epistasis inferred rather than reconstituted
   • Findings in disease model; baseline physiological relevance unclear
5. 2024 High

   Provided definitive functional proof that NDUFA3 is required for complex I and complex IV stability and that a patient mutation abolishes this function.

   Evidence Knockdown in patient fibroblasts and HEK293T cells, wild-type vs p.Arg58His mutant rescue, BN-PAGE, Seahorse respiration/ATP, zebrafish morpholino locomotor assay

   PMID:41038977

   Open questions at the time

   • Mechanism by which NDUFA3 loss secondarily destabilizes complex IV not explained
   • Single patient mutation tested for rescue
   • Zebrafish phenotype not mapped to specific respiratory defect
6. 2024 Medium

   Identified NDUFA3 as a Leigh syndrome disease gene through familial genetic and splicing evidence.

   Evidence Whole exome sequencing, minigene splicing assay, and clinical/radiological characterization in three siblings

   PMID:39661167

   Open questions at the time

   • Single family; no direct biochemical rescue performed
   • Genotype-phenotype correlation limited to one kindred
7. 2025 High

   Defined a non-coding splicing mechanism for NDUFA3-related disease and confirmed causality by functional rescue.

   Evidence Whole genome sequencing, RNA-seq splicing analysis, phasing, and wild-type overexpression rescue in patient fibroblasts

   PMID:41404351

   Open questions at the time

   • Alu-element exonization mechanism characterized in patient cells only
   • Phenotypic spectrum across patients not delineated

• How NDUFA3 loss leads to secondary complex IV destabilization, and the precise atomic mechanism by which it nucleates Q module assembly, remain unresolved.
• No structural model of mammalian NDUFA3 in situ
• Coupling between complex I and complex IV stability mechanistically undefined
• Direct transcription factor occupancy at the NDUFA3 locus not demonstrated